How does ocular syphilis present in an adult patient with a history of sexually transmitted infections or immunocompromised status, such as Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Presentation of Ocular Syphilis

Ocular syphilis most commonly presents as posterior uveitis or panuveitis, with visual acuity often severely impaired at presentation (worse than 6/60 in over half of cases), and can affect virtually any ocular structure at any stage of syphilis infection. 1, 2

Primary Clinical Manifestations

Anatomic Distribution

  • Posterior uveitis is the most frequent presentation (approximately 54% of cases), followed by panuveitis (31%), anterior uveitis (15%), and optic neuritis 1, 2, 3
  • Panuveitis occurs more commonly in HIV-infected patients with CD4 counts <200 cells/mm³ 4
  • Diffuse necrotizing retinitis is significantly more common in HIV-positive patients compared to HIV-negative patients 3

Visual Acuity at Presentation

  • Over 50% of patients present with visual acuity worse than 6/60 (20/200), indicating severe visual impairment at initial diagnosis 2
  • Approximately 38% present with visual acuity between 6/15 to 6/60 2
  • Only 8% present with visual acuity of 6/12 or better 2

Specific Ocular Symptoms and Signs

Patient-Reported Symptoms

  • Blurred vision or decreased visual acuity 5
  • Eye pain or ocular discomfort 5
  • Photophobia (light sensitivity) 5
  • Floaters or visual field defects (with posterior involvement) 6

Clinical Examination Findings

  • Uveitis (anterior, posterior, or panuveitis) is the hallmark finding requiring slit-lamp examination for confirmation 1
  • Iritis or iris involvement may occur as part of tertiary syphilis 1, 7
  • Optic nerve involvement including optic neuritis 2, 8
  • Macular edema (associated with worse visual prognosis) 8
  • Vitritis and retinal vasculitis 6, 3

HIV-Specific Considerations

Presentation Differences

  • Ocular syphilis leads to initial HIV diagnosis in 52% of HIV-infected cases, including patients with CD4 counts >200 cells/mm³ 4
  • Approximately 31% of HIV-positive patients are newly diagnosed with HIV at the time of ocular syphilis presentation 3
  • Posterior uveitis is significantly more common when CD4 count <200 cells/mm³ (p = 0.002) 4
  • Ocular co-infections (especially tuberculosis) are more common in HIV-positive patients 3

Visual Outcomes

  • HIV status, CD4 cell count, and HIV viral load do NOT predict visual acuity outcomes after treatment, contrary to what might be expected 8
  • Both HIV-positive and HIV-negative patients show similar rates of visual improvement with appropriate treatment 8, 3

Diagnostic Pitfalls and Critical Warnings

Serologic Testing Limitations

  • Three percent of confirmed ocular syphilis cases may have negative non-treponemal tests (RPR/VDRL), particularly in HIV-infected patients 4
  • If clinical suspicion is high despite negative non-treponemal testing, treponemal-specific tests and repeat testing should be pursued 4

Neurosyphilis Association

  • CSF abnormalities occur in 10-60% of patients with ocular syphilis, indicating frequent concurrent neurosyphilis 1
  • Up to 50% have reactive CSF VDRL results 1
  • However, CSF examination is NOT mandatory for isolated ocular findings with confirmed syphilis serology and ocular abnormalities on examination, as nearly 40% will have normal CSF 1

Prognostic Factors

Predictors of Poor Visual Outcome

  • Visual acuity ≥1.00 logMAR (20/200 or worse) at presentation is the strongest predictor of poor final visual acuity 8
  • Female sex is associated with worse visual outcomes 8
  • Presence of macular edema predicts worse final visual acuity 8
  • Longer duration of symptoms before treatment correlates with worse outcomes 1

Expected Treatment Response

  • 84-97% of patients show visual improvement of at least one Snellen line after appropriate treatment 2, 4
  • Complete resolution of ocular inflammation occurs in approximately 95% of treated patients 3
  • Visual acuity of 6/12 (20/40) or better increases from 8% at presentation to 31% after treatment 2

Stage of Syphilis at Presentation

  • Secondary syphilis is the most common stage when ocular involvement presents (approximately 73% of cases) 3
  • Ocular syphilis can occur at any stage: primary, secondary, early latent, or tertiary infection 2, 6
  • Acute inflammation typically occurs during primary, secondary, and early latent stages 2
  • Chronic inflammation (including iris gumma) occurs during tertiary infection 7, 2

Demographics

  • Males are predominantly affected (86% in some series), likely reflecting higher rates of syphilis infection in men who have sex with men 3
  • Mean age of presentation is approximately 70 years in HIV-negative populations, though this varies widely 2
  • HIV-infected patients tend to present at younger ages 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Syphilis Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Ocular Syphilis: a Clinical Review.

Current infectious disease reports, 2016

Guideline

Clinical Management of Iris Gumma in Tertiary Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.